Nymox Pharmaceutical (NYMXF) Q3 2022 Earnings

16NovExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.06
-0.04
-0.01
0.01

Details

Expected EPS
0
Actual EPS
-0.02
Surprise EPS
-0.02
Surprise Percent
+∞%

Description

Nymox Pharmaceutical (NYMXF) has reported earnings of -0.02 per share for Q3 2022.

0 Comments

Share your thoughts